BACKGROUND: Ablation of scar-related ventricular tachycardia (VT), especially in noninducible VT or hemodynamically unstable patients, can be challenging. Thus, we evaluated feasibility of an ultra high-density 3-D mapping approach to characterize the ventricular substrate and, if possible, to map VT. METHODS AND RESULTS: Twenty-two patients (67 ± 2 years, mean LV-EF 36 ± 3%) with both ischemic and nonischemic cardiomyopathy and documented VT underwent mapping and catheter ablation using a 64-electrode mini-basket catheter. Substrate characterization included ultra high-density voltage maps, identification of areas of slow conduction and late potentials. Whenever VT was inducible activation mapping was performed. In 13 of 22 patients, the presumed clinical VT (in 16 of 22 any VT) was inducible. A total of 50 maps were generated (22 substrate maps, 28 during VT), mapping time was 33 ± 4 minutes, number of points was 10,937 ± 1,923. Low voltage areas were related with the site of origin in all mapped VT. Isochronal maps indicated areas of slow conduction in 14 of 22 patients, all in border zone scar. In 95% of patients, late potentials were found. Mapping time during VT was 9 ± 2 minutes, number of points 6,740 ± 1,140. Covered cycle length was 82 ± 5% (16 re-entry, 10 focal, and two undetermined). During 4 months follow-up, 90% remained free from VT recurrence. CONCLUSION: Ultra high-density mapping in patients with scar-related VT is feasible, safe and enables detailed insight into tachycardia mechanisms. Critical sites can be identified (1) by precise substrate characterization when VT is not inducible or hemodynamically not tolerated and (2) during short lasting episodes of VT in order to guide catheter ablation.
BACKGROUND: Ablation of scar-related ventricular tachycardia (VT), especially in noninducible VT or hemodynamically unstable patients, can be challenging. Thus, we evaluated feasibility of an ultra high-density 3-D mapping approach to characterize the ventricular substrate and, if possible, to map VT. METHODS AND RESULTS: Twenty-two patients (67 ± 2 years, mean LV-EF 36 ± 3%) with both ischemic and nonischemic cardiomyopathy and documented VT underwent mapping and catheter ablation using a 64-electrode mini-basket catheter. Substrate characterization included ultra high-density voltage maps, identification of areas of slow conduction and late potentials. Whenever VT was inducible activation mapping was performed. In 13 of 22 patients, the presumed clinical VT (in 16 of 22 any VT) was inducible. A total of 50 maps were generated (22 substrate maps, 28 during VT), mapping time was 33 ± 4 minutes, number of points was 10,937 ± 1,923. Low voltage areas were related with the site of origin in all mapped VT. Isochronal maps indicated areas of slow conduction in 14 of 22 patients, all in border zone scar. In 95% of patients, late potentials were found. Mapping time during VT was 9 ± 2 minutes, number of points 6,740 ± 1,140. Covered cycle length was 82 ± 5% (16 re-entry, 10 focal, and two undetermined). During 4 months follow-up, 90% remained free from VT recurrence. CONCLUSION: Ultra high-density mapping in patients with scar-related VT is feasible, safe and enables detailed insight into tachycardia mechanisms. Critical sites can be identified (1) by precise substrate characterization when VT is not inducible or hemodynamically not tolerated and (2) during short lasting episodes of VT in order to guide catheter ablation.
Authors: Shinwan Kany; Fares Alexander Alken; Ruben Schleberger; Jakub Baran; Armin Luik; Annika Haas; Elena Ene; Thomas Deneke; L Dinshaw; Andreas Rillig; Andreas Metzner; Bruno Reissmann; Hisaki Makimoto; Tilko Reents; Miruna Andrea Popa; Isabel Deisenhofer; Roman Piotrowski; Piotr Kulakowski; Paulus Kirchhof; Katharina Scherschel; Christian Meyer Journal: Europace Date: 2022-07-15 Impact factor: 5.486
Authors: Mariña López-Yunta; Daniel G León; José Manuel Alfonso-Almazán; Manuel Marina-Breysse; Jorge G Quintanilla; Javier Sánchez-González; Carlos Galán-Arriola; Victoria Cañadas-Godoy; Daniel Enríquez-Vázquez; Carlos Torres; Borja Ibáñez; Julián Pérez-Villacastín; Nicasio Pérez-Castellano; José Jalife; Mariano Vázquez; Jazmín Aguado-Sierra; David Filgueiras-Rama Journal: Europace Date: 2019-01-01 Impact factor: 5.214
Authors: Hanna Jankowska; Karolina Dorniak; Marcin Hellmann; Anna Dubaniewicz; Maria Dudziak Journal: Arch Med Sci Date: 2019-07-18 Impact factor: 3.318
Authors: Rui Shi; Zhong Chen; Andrianos Kontogeorgis; Frederic Sacher; Paolo Della Bella; Caterina Bisceglia; Ruairidh Martin; Christian Meyer; Stephan Willems; Vias Markides; Philippe Maury; Tom Wong Journal: J Am Heart Assoc Date: 2018-11-06 Impact factor: 5.501